Introduction:Basic information about CAS 98206-09-8|Eltoprazine (hydrochloride), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Eltoprazine (hydrochloride) |
|---|
| CAS Number | 98206-09-8 | Molecular Weight | 256.72900 |
|---|
| Density | 1.18g/cm3 | Boiling Point | 384.3ºC at 760 mmHg |
|---|
| Molecular Formula | C12H17ClN2O2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 186.2ºC |
|---|
Names
| Name | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine |
|---|
| Synonym | More Synonyms |
|---|
Eltoprazine (hydrochloride) BiologicalActivity
| Description | Eltoprazine(DU28853) is a serenic or antiaggressive agent which as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.IC50 value:Target: 5-HT1A/1B agonist; 5-HT2C antagonistin vitro: The binding of [3H]eltoprazine to whole tissue sections was saturable and revealed an apparent dissociation constant (Kd) of 11 nM. Specific [3H]eltoprazine binding was completely displaced by 5-HT; conversely, unlabelled eltoprazine reduced [3H]5-HT binding to the levels of non-specific binding [1]. Eltoprazine evoked membrane changes that were similar to but much weaker than those induced by 5HT. Both the 5HT- and eltoprazine-evoked membrane hyperpolarizations were largely suppressed in the presence of spiperone [2].in vivo: eltoprazine is extremely effective in suppressing dyskinesia in experimental models, although this effect was accompanied by a partial worsening of the therapeutic effect of l-dopa. Interestingly, eltoprazine was found to (synergistically) potentiate the antidyskinetic effect of amantadine. The current data indicated that eltoprazine is highly effective in counteracting dyskinesia in preclinical models [3]. Rats were chronically treated with mianserin (10 mg/kg i.p.) or eltoprazine (1 mg/kg i.p.) and were tested in the elevated plus-maze test for anxiety. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones [4]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>5-HT ReceptorSignaling Pathways >>Neuronal Signaling >>5-HT ReceptorResearch Areas >>Neurological Disease |
|---|
| References | [1]. Sijbesma H, et al. Eltoprazine, a drug which reduces aggressive behaviour, binds selectively to 5-HT1 receptor sites in the rat brain: an autoradiographic study. Eur J Pharmacol. 1990 Feb 20;177(1-2):55-66. [2]. Joels M, et al. Eltoprazine suppresses hyperpolarizing responses to serotonin in rat hippocampus. J Pharmacol Exp Ther. 1990 Apr;253(1):284-9. [3]. Bezard E, et al. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord. 2013 Jul;28(8):1088-96. [4]. Rocha B, et al. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels. Eur J Pharmacol. 1994 Sep 1;262(1-2):125-31. |
|---|
Chemical & Physical Properties
| Density | 1.18g/cm3 |
|---|
| Boiling Point | 384.3ºC at 760 mmHg |
|---|
| Molecular Formula | C12H17ClN2O2 |
|---|
| Molecular Weight | 256.72900 |
|---|
| Flash Point | 186.2ºC |
|---|
| Exact Mass | 256.09800 |
|---|
| PSA | 33.73000 |
|---|
| LogP | 2.06320 |
|---|
| Index of Refraction | 1.562 |
|---|
| InChIKey | JFSOSUNPIXJCIX-UHFFFAOYSA-N |
|---|
| SMILES | Cl.c1cc2c(c(N3CCNCC3)c1)OCCO2 |
|---|
Synonyms
| Eltoprazinum [Latin] |
| Eltoprazine |
| Eltoprazina |
| Eltoprazina [Spanish] |
| 1-(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)piperazine |
| Eltoprazine hydrochloride |
| Eltoprazine (hydrochloride) |